CLINICAL_TRIALS
trial_result
· 2013-06-21
Clinical Trial Update: A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma [Phase 2]
Summary
A Phase 2 trial evaluating Revamilast for chronic persistent asthma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Glenmark Pharmaceuticals Ltd. India | Conditions: Asthma | Phase 2 | Status: COMPLETED